Correlation
The correlation between KVUE and TEVA is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
KVUE vs. TEVA
Compare and contrast key facts about Kenvue Inc. (KVUE) and Teva Pharmaceutical Industries Limited (TEVA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KVUE or TEVA.
Performance
KVUE vs. TEVA - Performance Comparison
Loading data...
Key characteristics
KVUE:
1.11
TEVA:
-0.01
KVUE:
1.82
TEVA:
0.39
KVUE:
1.22
TEVA:
1.05
KVUE:
0.87
TEVA:
0.00
KVUE:
4.53
TEVA:
0.01
KVUE:
6.32%
TEVA:
18.15%
KVUE:
27.65%
TEVA:
48.12%
KVUE:
-33.22%
TEVA:
-90.80%
KVUE:
-6.29%
TEVA:
-74.95%
Fundamentals
KVUE:
$45.27B
TEVA:
$20.35B
KVUE:
$0.56
TEVA:
-$1.15
KVUE:
1.10
TEVA:
1.29
KVUE:
2.96
TEVA:
1.22
KVUE:
4.50
TEVA:
3.21
KVUE:
$15.30B
TEVA:
$16.61B
KVUE:
$8.88B
TEVA:
$8.17B
KVUE:
$3.06B
TEVA:
$1.37B
Returns By Period
In the year-to-date period, KVUE achieves a 13.90% return, which is significantly higher than TEVA's -23.87% return.
KVUE
13.90%
2.03%
0.98%
30.42%
N/A
N/A
N/A
TEVA
-23.87%
8.19%
-0.00%
-0.71%
22.63%
6.02%
-11.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KVUE vs. TEVA — Risk-Adjusted Performance Rank
KVUE
TEVA
KVUE vs. TEVA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Kenvue Inc. (KVUE) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
KVUE vs. TEVA - Dividend Comparison
KVUE's dividend yield for the trailing twelve months is around 3.44%, while TEVA has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KVUE Kenvue Inc. | 3.44% | 3.79% | 1.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.07% | 2.38% |
Drawdowns
KVUE vs. TEVA - Drawdown Comparison
The maximum KVUE drawdown since its inception was -33.22%, smaller than the maximum TEVA drawdown of -90.80%. Use the drawdown chart below to compare losses from any high point for KVUE and TEVA.
Loading data...
Volatility
KVUE vs. TEVA - Volatility Comparison
The current volatility for Kenvue Inc. (KVUE) is 7.57%, while Teva Pharmaceutical Industries Limited (TEVA) has a volatility of 16.55%. This indicates that KVUE experiences smaller price fluctuations and is considered to be less risky than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
KVUE vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between Kenvue Inc. and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KVUE vs. TEVA - Profitability Comparison
KVUE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported a gross profit of 2.17B and revenue of 3.74B. Therefore, the gross margin over that period was 58.0%.
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported a gross profit of 1.88B and revenue of 3.89B. Therefore, the gross margin over that period was 48.2%.
KVUE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported an operating income of 558.00M and revenue of 3.74B, resulting in an operating margin of 14.9%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported an operating income of 519.00M and revenue of 3.89B, resulting in an operating margin of 13.3%.
KVUE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported a net income of 322.00M and revenue of 3.74B, resulting in a net margin of 8.6%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported a net income of 214.00M and revenue of 3.89B, resulting in a net margin of 5.5%.